
Geraniin
CAS No. 60976-49-0
Geraniin( —— )
Catalog No. M18888 CAS No. 60976-49-0
Geraniin has a protective effect against OVX-induced rat osteoporosis.Geraniin has cytotoxic activity towards cancer cells in vitro and in vivo.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 110 | In Stock |
![]() ![]() |
25MG | 177 | In Stock |
![]() ![]() |
50MG | 267 | In Stock |
![]() ![]() |
100MG | 408 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGeraniin
-
NoteResearch use only, not for human use.
-
Brief DescriptionGeraniin has a protective effect against OVX-induced rat osteoporosis.Geraniin has cytotoxic activity towards cancer cells in vitro and in vivo.
-
DescriptionGeraniin has a protective effect against OVX-induced rat osteoporosis. Geraniin has cytotoxic activity towards cancer cells in vitro and in vivo. Geraniin exerts inhibitory effects on osteoclast differentiation in vitro and suppresses Ti particle-induced osteolysis in vivo, is a potential natural compound for the treatment of wear particle induced osteolysis in prostheses failure. Geraniin has anti-oxidant activity, induces Nrf2-mediated expression of antioxidant enzymes HO-1 and NQO1, presumably via PI3K/AKT and ERK1/2 signaling pathways, thereby protecting cells from H2O2-induced oxidative cell death. Geraniin presents radioprotective effects by regulating DNA damage on splenocytes, exerting immunostimulatory capacities and inhibiting apoptosis of radiosensitive immune cells and jejunal crypt cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAromatase
-
RecptorAntioxidant
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number60976-49-0
-
Formula Weight952.64
-
Molecular FormulaC41H28O27
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 104.97 mM;
-
SMILESC1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C7C(=CC(=O)C(C7(O)O)(O6)O)C(=O)O3)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Finrozole
Finrozole (MPV 2213ad) is a novel selective aromatase inhibitor that is partially reversible for breast development.
-
Testolactone
Testolactone is an aromatase inhibitor, blocks conversion of androgens to estrogens.It is progesterone derivative with antineoplastic activity.?
-
Formestane
Formestane was the first selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast Y in post-menopausal women.